GoldBamboo.com - Knowledge is strong medicine
  

Effect of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers - Article


  Not Signed In - Sign In / Register




General Topics A-Z

Zinc Salts Lozenges

Halls Zinc Defense; Zinc Lozenges


Clinical Trial: Effect of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers

This study is currently recruiting patients.
Verified by Imperial College London September 2005

Sponsors and Collaborators: Imperial College London
Wexham GI Trust
Information provided by: Imperial College London
ClinicalTrials.gov Identifier: NCT00149149

Purpose

Zinc carnosine is a food supplement which is available in the health food shops. We wish to see if it can reduce intestinal swelling in people who take non steroidal anti-inflammatory (anti-swelling) drugs (NSAIDS).
Condition Intervention Phase
Reduction in NSAID related gut damage
  Drug: Zinc carnosine
 Phase I

MedlinePlus consumer health information 

Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study

Official Title: Use of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers Taking Non Steroidal Anti Inflammatory Drugs (NSAIDS):

Further Study Details: 
Primary Outcomes: Effect of Zinc Carnosine in reducing the gut damage caused by non steroidal anti inflammatory drugs
Secondary Outcomes: Differences in dyspepsia score; Differences in faecal calprotectin
Expected Total Enrollment:  12

Study start: May 2005

Eligibility

Ages Eligible for Study:  18 Years   -   35 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

  • Age 18-35

Exclusion Criteria:

  • Conditions known to alter intestinal permeability eg previous bowel surgery, caeliac disease

Conditions where NSAIDs are contraindicated eg asthma, renal failure, heart failure

Diabetes

Any other serious ilness

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00149149

Asif Mahmood, MD      02083838067    asif.mahmood@imperial.ac.uk

United Kingdom
      Imperial College, London,  W12 0NN,  United Kingdom; Recruiting
Asif Mahmood, MD  02083838067    asif.mahmood@imperial.ac.uk 
Asif Mahmood, MRCP,  Sub-Investigator
Raymond Playford, FRCP PhD,  Principal Investigator

Study chairs or principal investigators

Raymond Playford, MD PhD,  Principal Investigator,  Imperial College   

More Information

Study ID Numbers:  05/Q0408/19
Last Updated:  September 7, 2005
Record first received:  September 7, 2005
ClinicalTrials.gov Identifier:  NCT00149149
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency
ClinicalTrials.gov processed this record on 2005-09-13


Source: ClinicalTrials.gov
Cache Date: September 14, 2005

Resources



Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Zinc Salts Lozenges.

November 18, 2008


Page Updated: June 1, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.